Novel protein pp3501 mediates the inhibitory effect of sodium butyrate on SH-SY5Y cell proliferation

Journal of Cellular Biochemistry

Volumn 113, Issue 8, 2012, Pages 2696-2703

  Wang, Yajun ^a   Ma, Chao ^a   Zhang, Haitao ^a   Wu, Jun ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Localization; pp3501; Recombinant; SH SY5Y cell; Sodium butyrate

Indexed keywords

BUTYRIC ACID; CELL PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; PROTEIN PP3501; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G1 PHASE; CELL NUCLEUS; CELL PROLIFERATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

BUTYRATES; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; NEUROBLASTOMA; PROTEINS;

EID: 84862572362     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24145     Document Type: Article

References (19)

1. Bandyopadhyay D, Mishra A, Medrano EE. 2004. Overexpression of histone deacetylase 1 confers resistance to sodium butyrate-mediated apoptosis in melanoma cells through a p53-mediated pathway. Cancer Res 64:7706-7710. (Pubitemid 39446901)
2. Blottiere HM, Buecher B, Galmiche JP, Cherbut C. 2003. Molecular analysis of the effect of short-chain fatty acids on intestinal cell proliferation, Proc Nutr Soc 62:101-106. (Pubitemid 36569815)
3. Cho SD, Ahn NS, Jung JW, Yang SR, Park JS, Lee YS, Jo EH, Hwang JW, Lii J, Kang KS. 2006. Critical role of the c-JunNH2-terminal kinase and p38 mitogen-activated protein kinase pathways on sodium butyrate-induced apoptosis in DU145 human prostate cancer cells. Eur J Cancer Prev 15: 57-63. (Pubitemid 43048744)
4. Finzer P, Kuntzen C, Soto U, zur Hausen H, Rosl F. 2001. Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression. Oncogene 20: 4768-4776. (Pubitemid 32803148)
5. Hara I, Miyake H, Hara S, Arakawa S, Kamidono S. 2000. Sodium butyrate induces apoptosis in human renal cell carcinoma cells and synergistically enhances their sensitivity to anti-Fas-mediated cytotoxicity. Int J Oncol 17:1213-1218.
6. Lane AA, Chabner BA. 2009. Histone deacetylase inhibitors in cancer therapy. J Clin Oncol 27:5459-5468.
7. Liu XH, Chen GG, Vlantis AC, Tse GM, van Hasselt CA. 2010. Iodine induces apoptosis via regulating MAPKs-related p53, p21, and Bcl-xL in thyroid cancer cells. Mol Cell Endocrinol 320:128-135.
8. Louis M, Rosato RR, Brault L, Osbild S, Battaglia E, Yang XH, Grant S, Bagrel D. 2004. The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress. Int J Oncol 25:1701-1711.
9. Ma X, Ezzeldin HH, Diasio RB. 2009. Histone deacetylase inhibitors: Current status and overview of recent clinical trials. Drugs 69:1911-1934.
10. Mohana Kumar B, Song HJ, Cho SK, Balasubramanian S, Choe SY, Rho GJ. 2007. Effect of histone acetylation modification with sodium butyrate, a histone deacetylase inhibitor, on cell cycle, apoptosis, ploidy and gene expression in porcine fetal fibroblasts. J Reprod Dev 53:903-913. (Pubitemid 47397292)
11. Ogawa K, Yasumura S, Atarashi Y, Minemura M, Miyazaki T, Iwamoto M, Higuchi K, Watanabe A. 2004. Sodium butyrate enhances Fas-mediated apoptosis of human hepatoma cells. J Hepatol 40:278-284. (Pubitemid 38115833)
12. Pajak B, Orzechowski A, Gajkowska B. 2007. Molecular basis of sodium butyrate-dependent proapoptotic activity in cancer cells. Adv Med Sci 52: 83-88.
13. Pajak B, Gajkowska B, Orzechowski A. 2009. Sodium butyrate sensitizes human colon adenocarcinoma COLO 205 cells to both intrinsic and TNF-alpha- dependent extrinsic apoptosis. Apoptosis 14:203-217.
14. Ruemmele FM, Schwartz S, Seidman EG, Dionne S, Levy E, Lentze MJ. 2003. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut 52:94-100. (Pubitemid 36020773)
15. Singh Narendra, Henry P, Lai C. 2005. Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells. Anticancer Res 25:4325-4331.
16. Wan D, Gong Y, Qin W, Zhang P, Li J, Wei L, Zhou X, Li H, Qiu X, Zhong F, He L, Yu J, Yao G, Jiang H, Qian L, Yu Y, Shu H, Chen X, Xu H, Guo M, Pan Z, Chen Y, Ge C, Yang S, Gu J. 2004. Large-scale cDNA transfection screening for genes related to cancer development and progression. PNAS 101:15724-15729. (Pubitemid 39473555)
17. Wang A, Zeng R, Huang H. 2008. Retinoic acid and sodium butyrate as cell cycle regulators in the treatment of oral squamous carcinoma cells. Oncol Res 17:175-182.
18. Wenqi D, Li W, Shanshan C, Bei C, Yafei Z, Feihu B, Jie L, Daiming F. 2009. EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer. J Cancer Res Clin Oncol 135:1277-1285.
19. Zhang HT, Feng ZL, Wu J, Wang YJ, Guo X, Liang NC, Zhu ZY, Ma JQ. 2007. Sodium butyrate-induced death-associated protein kinase expression promote Raji cell morphological change and apoptosis by reducing FAK protein levels. Acta Pharmacol Sin 28:1783-1790. (Pubitemid 350029329)